immunogen inc (IMGN:NASDAQ GS)
Gregory D. Perry
|Age||Total Calculated Compensation||This person is connected to 23 board members in 2 different organizations across 12 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Gregory D. Perry, also known as Greg, has been the Chief Financial Officer at Aegerion Pharmaceuticals, Inc. since July 6, 2015. Mr. Perry served as the Chief Financial & Business Officer at Eleven Biotherapeutics, Inc. from December 2013 to July 3, 2015. He served as an Interim Chief Financial Officer of InVivo Therapeutics Holdings Corp. from September 23, 2013 to December 30, 2013. He served as the Chief Financial Officer at ImmunoGen, Inc. from 2009 to September ...
830 Winter StreetPhone: 781-895-0600
Waltham, Massachusetts 02451
Board Members Memberships*
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director, Chairman of Audit Committee and Member of Compensation Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|$1.5M||Compensation as of Fiscal Year 2014.|